Bank Of Montreal Cerus Corp Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$1.5 - $3.07 $34,297 - $70,195	22,865 New	22,865 $37,000
Q1 2022 May 12, 2022	SELL	$4.81 - $6.99 $70,389 - $102,291	-14,634 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.97 - $7.93 $8,925 - $11,855	1,495 Added 11.38%	14,634 $102,000
Q3 2021 Nov 12, 2021	BUY	$4.79 - $6.68 $62,935 - $87,768	13,139 New	13,139 $88,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.